Correlation Between Impinj and Enlivex Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Impinj and Enlivex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Impinj and Enlivex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Impinj Inc and Enlivex Therapeutics, you can compare the effects of market volatilities on Impinj and Enlivex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Impinj with a short position of Enlivex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Impinj and Enlivex Therapeutics.

Diversification Opportunities for Impinj and Enlivex Therapeutics

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Impinj and Enlivex is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Impinj Inc and Enlivex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enlivex Therapeutics and Impinj is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Impinj Inc are associated (or correlated) with Enlivex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enlivex Therapeutics has no effect on the direction of Impinj i.e., Impinj and Enlivex Therapeutics go up and down completely randomly.

Pair Corralation between Impinj and Enlivex Therapeutics

Allowing for the 90-day total investment horizon Impinj Inc is expected to generate 0.76 times more return on investment than Enlivex Therapeutics. However, Impinj Inc is 1.31 times less risky than Enlivex Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Enlivex Therapeutics is currently generating about -0.07 per unit of risk. If you would invest  15,852  in Impinj Inc on August 24, 2024 and sell it today you would earn a total of  2,978  from holding Impinj Inc or generate 18.79% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Impinj Inc  vs.  Enlivex Therapeutics

 Performance 
       Timeline  
Impinj Inc 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Impinj Inc are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady forward indicators, Impinj demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Enlivex Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Enlivex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Impinj and Enlivex Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Impinj and Enlivex Therapeutics

The main advantage of trading using opposite Impinj and Enlivex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Impinj position performs unexpectedly, Enlivex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enlivex Therapeutics will offset losses from the drop in Enlivex Therapeutics' long position.
The idea behind Impinj Inc and Enlivex Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated